In Situ Selection of a Human Rhabdomyosarcoma Resistant to Vincristine with Altered β-Tubulins

Janet A. Houghton, Peter J Houghton, Bonni J. Hazelton, Edwin C. Douglass

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

In order to simulate more closely conditions in which resistance to vincristine (VCR) is selected in human solid tumors, a human rhabdomyosarcoma grown as a xenograft in immune-deprived mice has been selected for resistance in situ. Karyotype analysis showed the resistant line, HxRh18/VCR-3, to have a diploid modal number, with no apparent translocations, whereas the predominant population in the parental, sensitive HxRh18 xenograft demonstrated a modal number near-tetrapbid with many marker chromosomes. From the rapid rate at which resistance was selected and from karyotypic evidence, data strongly suggest that HxRh18/VCR-3 was a subpopulation within the parent tumor. When grown in the same host, HxRh18/VCR-3 tumors accumulated less drug, and the rate of [3H]VCR loss was 5-fold greater than in HxRh18 tumors. Thus, accumulation and retention of [3H]VCR in HxRhl 8/VCR-3 resistant tumors was identical to that of [3H]vinblastine (VLB) in HxRh18 xenografts. HxRh18 xenografts are intrinsically resistant to VLB. Analysis by high-performance liquid chromatography of [3H]VCR:protein complexes in HxRh18 cytosols indicated one binding species (Mr 95,000 to 116,000), probably the tubulin heterodimer. Of interest was the observation that β-tubulin species, identified on Western blots by monoclonal antibody, differed in these tumors. In HxRhl 8/VCR-3, less acidic β-tubulins of HxRh18 were decreased or absent, with three additional more acidic isoforms present in the resistant line. As vincristine may bind to the β-subunit of tubulin, this may have importance to vincristine resistance in vivo.

Original languageEnglish (US)
Pages (from-to)2706-2712
Number of pages7
JournalCancer Research
Volume45
Issue number6
StatePublished - Jun 1 1985
Externally publishedYes

Fingerprint

Rhabdomyosarcoma
Vincristine
Tubulin
Heterografts
Neoplasms
Vinblastine
Diploidy
Karyotype
Genetic Markers
Cytosol
Protein Isoforms
Western Blotting
High Pressure Liquid Chromatography
Monoclonal Antibodies

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

In Situ Selection of a Human Rhabdomyosarcoma Resistant to Vincristine with Altered β-Tubulins. / Houghton, Janet A.; Houghton, Peter J; Hazelton, Bonni J.; Douglass, Edwin C.

In: Cancer Research, Vol. 45, No. 6, 01.06.1985, p. 2706-2712.

Research output: Contribution to journalArticle

Houghton, JA, Houghton, PJ, Hazelton, BJ & Douglass, EC 1985, 'In Situ Selection of a Human Rhabdomyosarcoma Resistant to Vincristine with Altered β-Tubulins', Cancer Research, vol. 45, no. 6, pp. 2706-2712.
Houghton, Janet A. ; Houghton, Peter J ; Hazelton, Bonni J. ; Douglass, Edwin C. / In Situ Selection of a Human Rhabdomyosarcoma Resistant to Vincristine with Altered β-Tubulins. In: Cancer Research. 1985 ; Vol. 45, No. 6. pp. 2706-2712.
@article{a385c72eedec46fdaffaecd52d981ec2,
title = "In Situ Selection of a Human Rhabdomyosarcoma Resistant to Vincristine with Altered β-Tubulins",
abstract = "In order to simulate more closely conditions in which resistance to vincristine (VCR) is selected in human solid tumors, a human rhabdomyosarcoma grown as a xenograft in immune-deprived mice has been selected for resistance in situ. Karyotype analysis showed the resistant line, HxRh18/VCR-3, to have a diploid modal number, with no apparent translocations, whereas the predominant population in the parental, sensitive HxRh18 xenograft demonstrated a modal number near-tetrapbid with many marker chromosomes. From the rapid rate at which resistance was selected and from karyotypic evidence, data strongly suggest that HxRh18/VCR-3 was a subpopulation within the parent tumor. When grown in the same host, HxRh18/VCR-3 tumors accumulated less drug, and the rate of [3H]VCR loss was 5-fold greater than in HxRh18 tumors. Thus, accumulation and retention of [3H]VCR in HxRhl 8/VCR-3 resistant tumors was identical to that of [3H]vinblastine (VLB) in HxRh18 xenografts. HxRh18 xenografts are intrinsically resistant to VLB. Analysis by high-performance liquid chromatography of [3H]VCR:protein complexes in HxRh18 cytosols indicated one binding species (Mr 95,000 to 116,000), probably the tubulin heterodimer. Of interest was the observation that β-tubulin species, identified on Western blots by monoclonal antibody, differed in these tumors. In HxRhl 8/VCR-3, less acidic β-tubulins of HxRh18 were decreased or absent, with three additional more acidic isoforms present in the resistant line. As vincristine may bind to the β-subunit of tubulin, this may have importance to vincristine resistance in vivo.",
author = "Houghton, {Janet A.} and Houghton, {Peter J} and Hazelton, {Bonni J.} and Douglass, {Edwin C.}",
year = "1985",
month = "6",
day = "1",
language = "English (US)",
volume = "45",
pages = "2706--2712",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - In Situ Selection of a Human Rhabdomyosarcoma Resistant to Vincristine with Altered β-Tubulins

AU - Houghton, Janet A.

AU - Houghton, Peter J

AU - Hazelton, Bonni J.

AU - Douglass, Edwin C.

PY - 1985/6/1

Y1 - 1985/6/1

N2 - In order to simulate more closely conditions in which resistance to vincristine (VCR) is selected in human solid tumors, a human rhabdomyosarcoma grown as a xenograft in immune-deprived mice has been selected for resistance in situ. Karyotype analysis showed the resistant line, HxRh18/VCR-3, to have a diploid modal number, with no apparent translocations, whereas the predominant population in the parental, sensitive HxRh18 xenograft demonstrated a modal number near-tetrapbid with many marker chromosomes. From the rapid rate at which resistance was selected and from karyotypic evidence, data strongly suggest that HxRh18/VCR-3 was a subpopulation within the parent tumor. When grown in the same host, HxRh18/VCR-3 tumors accumulated less drug, and the rate of [3H]VCR loss was 5-fold greater than in HxRh18 tumors. Thus, accumulation and retention of [3H]VCR in HxRhl 8/VCR-3 resistant tumors was identical to that of [3H]vinblastine (VLB) in HxRh18 xenografts. HxRh18 xenografts are intrinsically resistant to VLB. Analysis by high-performance liquid chromatography of [3H]VCR:protein complexes in HxRh18 cytosols indicated one binding species (Mr 95,000 to 116,000), probably the tubulin heterodimer. Of interest was the observation that β-tubulin species, identified on Western blots by monoclonal antibody, differed in these tumors. In HxRhl 8/VCR-3, less acidic β-tubulins of HxRh18 were decreased or absent, with three additional more acidic isoforms present in the resistant line. As vincristine may bind to the β-subunit of tubulin, this may have importance to vincristine resistance in vivo.

AB - In order to simulate more closely conditions in which resistance to vincristine (VCR) is selected in human solid tumors, a human rhabdomyosarcoma grown as a xenograft in immune-deprived mice has been selected for resistance in situ. Karyotype analysis showed the resistant line, HxRh18/VCR-3, to have a diploid modal number, with no apparent translocations, whereas the predominant population in the parental, sensitive HxRh18 xenograft demonstrated a modal number near-tetrapbid with many marker chromosomes. From the rapid rate at which resistance was selected and from karyotypic evidence, data strongly suggest that HxRh18/VCR-3 was a subpopulation within the parent tumor. When grown in the same host, HxRh18/VCR-3 tumors accumulated less drug, and the rate of [3H]VCR loss was 5-fold greater than in HxRh18 tumors. Thus, accumulation and retention of [3H]VCR in HxRhl 8/VCR-3 resistant tumors was identical to that of [3H]vinblastine (VLB) in HxRh18 xenografts. HxRh18 xenografts are intrinsically resistant to VLB. Analysis by high-performance liquid chromatography of [3H]VCR:protein complexes in HxRh18 cytosols indicated one binding species (Mr 95,000 to 116,000), probably the tubulin heterodimer. Of interest was the observation that β-tubulin species, identified on Western blots by monoclonal antibody, differed in these tumors. In HxRhl 8/VCR-3, less acidic β-tubulins of HxRh18 were decreased or absent, with three additional more acidic isoforms present in the resistant line. As vincristine may bind to the β-subunit of tubulin, this may have importance to vincristine resistance in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0021933192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021933192&partnerID=8YFLogxK

M3 - Article

C2 - 3986804

AN - SCOPUS:0021933192

VL - 45

SP - 2706

EP - 2712

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 6

ER -